Download words

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report: April 1, 2016
Date of earliest event reported: March 28, 2016
Hooper Holmes, Inc.
(Exact name of registrant as specified in charter)
New York
(State or other jurisdiction
of incorporation)
1-9972
(Commission File Number)
22-1659359
(IRS Employer Identification No.)
560 N. Rogers Road, Olathe, Kansas 66062
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code ( 913) 764-1045
N/A
(Former names or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions ( see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 2.02
Results of Operations and Financial Condition.
On March 29, 2016, the Company issued a press release announcing its preliminary operating results and financial condition for the
quarter and year ended December 31, 2015. A copy of the press release is attached hereto as Exhibit 99.1, which is incorporated herein by
reference. The presentation discussed during the fourth quarter investor call on March 29, 2016, is attached as Exhibit 99.2, which is also
incorporated herein by reference. The information furnished in this section of the Current Report on Form 8-K and Exhibits attached hereto
shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or
otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 3.02
Unregistered Sales of Equity Securities.
On March 31, 2016, the Company issued 714,286 shares of its common stock, par value $0.04 per share, to SWK FUnding LLC
("SWK") pursuant to the Second Amendment to Credit Agreement dated March 28, 2016 by adn between the Company and SWK (the
"SEcond Amendment"). The Second Amendment, the material terms of which were described int he Company's Annual Report on Form 10-K
for the year ended December 31, 2015, filed with the SEC on March 30, 2016 (the "Form 10-K"), amended the terms and conditions of that
certain Credit Agreement, dated as of April 17, 2015, as amended by that certain First Amendment to Credit Agreement, dated as of February
25, 2016, by and between the Company and SWK.
Item 7.01.
Regulation FD Disclosure.
The investor presentation attached as Exhibit 99.4 to this Current Report on Form 8-K and incorporated herein by reference will be
used at investor meetings in the month of April 2016. The information in item 7.01 of this Form 8-K and Exhibit 99.4 attached hereto shall not
be deemed filed for purposes of section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference.
Item 8.01
Other Events.
On March 29, 2016, the Company issued a press release announcing the execution of the Stock Purchase Agreement with 200 NNH,
LLC, the material terms of which were described in the Form 10-K. A copy of the press release is attached hereto as Exhibit 99.3 and
incorporated by reference herein
Item 9.01.
(d) Exhibits
Financial Statements and Exhibits.
Exhibit No.
Description
99.1
99.2
Press Release announcing preliminary earnings, dated March 29, 2016
Presentation used during the fourth quarter investor conference call on March 29, 2016
99.3
99.4
Press Release announcing Stock Purchase Agreement, dated March 29, 2016
Investor presentation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Dated: April 1, 2016
HOOPER HOLMES, INC.
By:
/s/ Steven R. Balthazor
Steven R. Balthazor
Chief Financial Officer
EXHIBIT INDEX
Exhibit No.
99.1
99.2
99.3
99.4
Description of Exhibit
Press Release announcing preliminary earnings, dated March 29, 2016
Presentation used during the fourth quarter investor conference call on March 29, 2016
Press Release announcing Stock Purchase Agreement, dated March 29, 2016
Investor presentation
1
Exhibit 99.1
News Release
For further information:
Hooper Holmes
Henry E. Dubois
President and CEO
(913) 764-1045
Investors: Andrew Berger
S.M. Berger & Company
(216) 464-6400
Hooper Holmes Announces 2015 Financial Results
OLATHE, Kan., Tuesday, March 29, 2016 -- Hooper Holmes, Inc. (NYSE MKT:HH) today announced financial
results for the fourth quarter and full year ended December 31, 2015.
For the fourth quarter of 2015, consolidated revenues from continuing operations totaled $9.5 million, a 42%
improvement compared to $6.7 million for the fourth quarter of 2014. The Company performed approximately 152,000
screening units for the fourth quarter of 2015, a 20% improvement compared to 127,000 screening units for the fourth
quarter of 2014.
For the year ended December 31, 2015, consolidated revenues from continuing operations were $32.1 million, an
increase of approximately ~13% from the prior year of $28.5 million, as screening unit growth offset reductions that
were expected from the previously announced end of a large clinical research contract. The Company's net loss for the
year ended December 31, 2015, was $10.9 million, compared to a net loss of $8.5 million for the year ended December
31, 2014. On an adjusted EBITDA basis, excluding one-time events, the Company's net loss for the year ended
December 31, 2015 was $4.5 million, a 35% improvement compared to 2014.
For the year ended December 31, 2015, the Company performed approximately 515,000 health screenings, an increase
of approximately 9% compared to 474,000 health screenings for the year ended December 31, 2014. As of December
31, 2015, cash and cash equivalents totaled $2.0 million, with $3.3 million in borrowings outstanding under the
Company’s credit facility. On January 27, 2016, the Company announced the results of a rights offering which raised
$3.5 million in new capital.
screening units for the fourth quarter of 2015, a 20% improvement compared to 127,000 screening units for the fourth
quarter of 2014.
For the year ended December 31, 2015, consolidated revenues from continuing operations were $32.1 million, an
increase of approximately ~13% from the prior year of $28.5 million, as screening unit growth offset reductions that
were expected from the previously announced end of a large clinical research contract. The Company's net loss for the
year ended December 31, 2015, was $10.9 million, compared to a net loss of $8.5 million for the year ended December
31, 2014. On an adjusted EBITDA basis, excluding one-time events, the Company's net loss for the year ended
December 31, 2015 was $4.5 million, a 35% improvement compared to 2014.
For the year ended December 31, 2015, the Company performed approximately 515,000 health screenings, an increase
of approximately 9% compared to 474,000 health screenings for the year ended December 31, 2014. As of December
31, 2015, cash and cash equivalents totaled $2.0 million, with $3.3 million in borrowings outstanding under the
Company’s credit facility. On January 27, 2016, the Company announced the results of a rights offering which raised
$3.5 million in new capital.
Henry Dubois, President and CEO of Hooper Holmes commented, "2015 was a transformational year for our business.
We integrated a major acquisition, introduced new Health and Wellness services, and signed new customers. In the first
quarter of 2016 we strengthened our capital structure and won new sales which we expect to contribute at least $3.3
million in new 2016 revenue. The
Hooper Holmes Confidential
2
Exhibit 99.1
year is off to a strong start, and we are making progress towards our 2016 financial goals of revenue in excess of $42
million and positive EBITDA and operating cash flow."
Conference Call
The Company will host a conference call today, Tuesday, March 29, 2016, at 7:30 a.m. CT (8:30 a.m. ET) to discuss
2015 financial results. A slide presentation will accompany the conference call and is available on the Company’s
website located at www.hooperholmes.com.
To participate in the conference call, please dial 888-438-5491, or internationally 719-785-1753 conference ID:
4689706 five to ten minutes before the call is scheduled to begin. A live webcast will be hosted on the Company's
website located at www.hooperholmes.com. A replay of the conference call will be available through April 5, 2016, by
dialing 877-870-5176, or internationally 858-384-5517. The access code for the replay is 4689706.
Sidoti Conference
On Thursday, March 31, 2016, Hooper Holmes will be participating at the Sidoti Emerging Growth Convention. The
conference will be held at the New York Marriott Marquis at Times Square. Henry Dubois, President and CEO of
Hooper Holmes, will present at 8:30 a.m. ET.
The Company will also meet one-on-one with institutional investors during the day. Investors interested in attending
and scheduling a one-on-one meeting with management should click the link below:
https://www.meetmax.com/sched/event_35923/investor_reg_new.html?cmd=register&event_id=35923&attendee_role
_id=INVESTOR.
The Company’s presentation will be available in the Investor Relations section of Hooper Holmes’ website:
http://www.hooperholmes.com/investors/.
About Hooper Holmes
Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory
testing, risk assessment and sample collection services to wellness and disease management companies, employers and
brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions
brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive
health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs.
More information is available at hooperholmes.com and at accountablehealthsolutions.com.
This press release contains “forward-looking” statements, as such term is defined in the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based on the Company’s current expectations and beliefs
and are subject to a number of risks, uncertainties and
Hooper Holmes Confidential
3
Exhibit 99.1
assumptions. Among the important factors that could cause actual results to differ materially from those expressed in,
or implied by, these forward-looking statements are our ability to realize the expected benefits from this acquisition
and our strategic alliance with Clinical Reference Laboratory; our ability to successfully implement our business
strategy and integrate Accountable Health Solutions’ business with ours; our ability to retain and grow our customer
base; our ability to recognize operational efficiencies and reduce costs; uncertainty as to our working capital
requirements over the next 12 to 24 months; our ability to maintain compliance with the financial covenant in our
credit facility and the financing for this acquisition; and the rate of growth in the Health and Wellness market.
Additional information about these and other factors that could affect the Company’s business is set forth in the
Company’s annual report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange
Commission on March 31, 2015. The Company undertakes no obligation to update or release any revisions to these
forward-looking statements to reflect events or circumstances after the date of this press release to reflect the
occurrence of unanticipated events, except as required by law.
Hooper Holmes Confidential
4
Exhibit 99.1
Adjusted net loss is not a recognized term under GAAP. These non-GAAP financial measures should not be substituted for GAAP net earnings
or GAAP diluted earnings per share, respectively, as measures of Hooper Holmes’ performance, but instead should be utilized as supplemental
measures of financial performance in evaluating our business.
Hooper Holmes Confidential
5
Exhibit 99.1
Hooper Holmes
Henry E. Dubois, 913-764-1045
President and CEO
or
Investors:
S.M. Berger & Company
Andrew Berger, 216-464-6400
Source: Hooper Holmes
News Provided by Acquire Media
Hooper Holmes Confidential
1 Hooper Holmes, Inc. March 29, 2016 Earnings Presentation Speakers: Henry Dubois, Chief Executive Officer Steven Balthazor, Chief Financial Officer
2 Safe Harbor Statement 2 This presentation contains forward-looking statements, as such term is defined in the Private Securities Litigation Reform Act of 1995, concerning the Company’s plans, objectives, goals, strategies, future events or performances, which are not statements
of historical fact and can be identified by words such as: “expect,” “continue,” “should,” “may,” “will,” “project,” “anticipate,” “believe,” “plan,” “goal,” and similar references to future periods. The forward-looking statements contained in this presentation reflect our current beliefs
and expectations. Actual results or performance may differ materially from what is expressed in the forward looking statements. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, the forward-looking statements
contained in this presentation are our ability to realize the expected benefits from the acquisition of Accountable Health Solutions and our strategic alliance with Clinical Reference Laboratory; our ability to successfully implement our business strategy and integrate Accountable
Health Solutions’ business with ours; our ability to retain and grow our customer base; our ability to recognize operational efficiencies and reduce costs; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the
financial covenants contained in our credit facilities; the rate of growth in the Health and Wellness market and such other factors as discussed in Part I, Item 1A, Risk Factors, and Part II, Item 7, Management’s Discussion and Analysis of Financial Conditions and Results of
Operations of our Annual Report on Form 10-K for the year ended December 31, 2014. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances, or to reflect the occurrence of unanticipated
events, after the date of this presentation, except as required by law. This presentation contains information from third-party sources, including data from studies conducted by others and market data and industry forecasts obtained from industry publications. Although the Company
believes that such information is reliable, the Company has not independently verified any of this information and the Company does not guarantee the accuracy or completeness of this information.
3 Q4 2015 Results Set Stage for Accelerated Growth FULL YEAR 2015 HIGHLIGHTS $32.1mm record Health & Wellness revenue 515,000 record screening units Transformed business model, reduced costs New sales in 2015 increased the revenue base for 2016 and
beyond Q4 2014 Q4 2015 +42% REVENUE $6.7mm $9.5mm 2016 OUTLOOK Successfully raised $3.5mm in rights offering and an additional $1.2mm from 200 NNH, LLC an affiliate of Kanon Ventures $42.0mm revenue expected for full year with positive EBITDA &
operating cash flow for full year Q1 is off to a good start Due to the seasonality of the business, ~60% of revenue historically comes in the second half Repayment of $2.3mm of debt planned in 2016 Q4 2014 Q4 2015 +22% GROSS MARGIN % 16.9% 20.7% Q4 2014 Q4
2015 +20% SCREENING UNITS 127,000 152,000
4 4 Consolidated Revenue ($mm) Screening Units Sequential and year-over-year revenue growth ̶ Q4 2015 revenue increased 42% compared to Q4 2014 ̶ Consolidated revenue, which includes screening and wellness services, increased 13% over full year 2014 Screening units
grew by 14% compared to full year 2014, excluding the impact of a large customer study in the clinical research segment ̶ As previously discussed, a large population study on smoking began to wind down in Q4 2014. Unit growth in our wellness business offset reductions in our
clinical research segment; we have since won a contract extension for this study worth $12.0mm over the life of the contract Key Takeaways # of S cr ee n in gs 2015 Results vs. 2014 42% Improvement over Q4 2014 R ev en u e in mill io n $ 13% Improvement over FY 2014 20%
Improvement over Q4 2014 9% Improvement over FY 2014 14% 19% $6.4 $9.3 $6.7 $9.5 0 2 4 6 8 10 12 Q4 2014 Q4 2015 43% $23.7 $31.1 $28.5 $32.1 0 5 10 15 20 25 30 35 40 2014 2015 31%
5 5 Adjusted EBITDA Excluding One-Time Events ($mm) 35% Improvement A d ju st ed E B IT D A in mil lio n $ 2015 Results vs. 2014 - continued Adjusted EBITDA excluding one-time events increased 35% over 2014 ‐ Second half Adjusted EBITDA improved 61% over
second half 2014 -$6.9 -$4.5 -12 -10 -8 -6 -4 -2 0 2 2014 2015 FY 2014 FY 2015 Net Loss ($8.5) ($10.9) Interest $0.0 $1.4 Deferred Financing $0.3 $0.4 Taxes $0.0 $0.0 Amortization $0.0 $0.9 Depreciation $1.2 $1.3 EBITDA ($6.9) ($6.8) Stock Compensation $0.5 $0.4
Transaction & transition costs $1.9 $1.7 Gain on sale of real estate & restructuring ($1.7) $0.0 Gain on sale of lab services ($0.9) $0.0 Close-out cost of 2013 Portamedic sale $0.2 $0.2 Adjusted EBITDA Excluding One-Time Events ($6.9) ($4.5)
6 Momentum Continues to Build New Sales Won in Q1 2016 and Associated Estimated 2016 Revenue ($mm) 20 1 6 n ew sales r ev en u e in m ill ion $ New Direct Customers Estimated $0.5mm in 2016 Contracts are typically multi-year New Clinical Research Organization
Revenue Estimated $0.9mm in 2016 Large contract extension estimated at $12.0mm in revenue over the life of the contract, $0.8mm in 2016 New Channel Partners Estimated $1.1mm in 2016 New End Customers Through Existing Channel Partners Estimated $0.9mm in
2016 We are positioned to grow with our Channel Partners $0.5 $0.9 $1.1 $0.9 $3.3 $0 $1 $2 $3 $4 2016 Estimated Revenue Impact Total New End Customers Through Channel Partners New Channel Partners New Clinical Research Organizations
7 Strengthened Capital Structure Rights Offering Successfully Completed in Q1 2016 ̶ Strong interest and shareholder support ̶ Raised $3.5mm ̶ Board and management as a group over subscribed and now hold ~10% of total shares ̶ 300+ individual shareholders participated
Additional Capital Raised in Q1 2016 ̶ 200 NNH, LLC, an affiliate of Kanon Ventures, Invested $1.2mm Debt ̶ Repayment of $2.3mm of debt planned for 2016 ̶ Principal payment made in Q1 2016 ̶ Meaningful interest expense reduction with each quarterly payment Cash added
through rights offering $3.5mm Cash added from investment by 200 NNH, LLC $1.2mm $7.0mm Revolving Line of Credit $1.5mm at 3/15 (credit line – amount drawn) SWK Term Loan $4.5mm Current Capital Structure Highlights
8 Hooper Wellness Programs Get Results Annual healthcare cost reduction of nearly $1.5mm; additional cost savings related to higher productivity, reduced absenteeism, ability to attract and retain top talent, and fewer safety incidents not included $2,680 $5,004 $7,230 $5,952
(Non-Participants) At Start of the Program Risk Transition Two Years Into the Program Low Risk 5,742 (76%) Moderate Risk 1,471 (20%) High Risk 293 (4%) High Risk 183 (3%) Moderate Risk 1,065 (14%) Low Risk 6,258 (83%) Low Risk (n=5,251) Moderate Risk (n=461)
High Risk (n=30) Low Risk (n=899) Moderate Risk (n=491) High Risk (n=81) Low Risk (n=108) Moderate Risk (n=113) High Risk (n=72) Average Annual Healthcare Cost Per Employee 7.3% net change in health risk status improvement 91% of the participants that started as a
low health risk stayed low health risk
9 2015 sales wins expected to drive $7.0mm of incremental revenue in 2016 $3.3mm of new 2016 revenue won through sales efforts already this year, including the addition of full service wellness clients Q1 2016 progressing toward annual goal For full year 2016,
expecting $42.0mm revenue representing 30% growth as compared to 2015 and continued progress toward achieving our $100mm revenue target Expecting positive EBITDA and operating cash flow for the full year New Sales Financial Growth Building Awareness 2016
Outlook: Accelerated Growth Q4 2015: LD Micro Conference February 22nd: Presented at SeeThruEquity Conference March 31st: Sidoti Emerging Growth Conference Drive Shareholder Value
Exhibit 99.3
News Release
For further information:
Hooper Holmes
Henry E. Dubois
President and CEO
(913) 764-1045
Investors: Andrew Berger
S.M. Berger & Company
(216) 464-6400
Hooper Holmes Announces $1.2 Million Investment by Kanon Ventures
OLATHE, Kan., Tuesday, March 29, 2016 -- Hooper Holmes, Inc. (NYSE MKT:HH) today announced a $1,200,000
private placement of its common stock to 200 NNH, LLC, an affiliate of Kanon Ventures, LLC. Pursuant to a securities
purchase agreement executed on March 28, 2016, the Company issued and sold 10,000,000 shares of its common stock
to 200 NNH at $0.12 per share, subject to an 18-month lock-up period.
Henry Dubois, President and CEO of Hooper Holmes commented, "This capital will support our growth and liquidity
and help continue to drive our business forward. We also look forward to benefitting from Kanon's experience in the
healthcare market, and their track record in building long-term value."
About Kanon Ventures
Kanon Ventures, LLC is a private equity firm with expertise in healthcare and real estate. For over 30 years, Kanon's
principals and management team have been industry-leading investors and operators, having owned and operated
hospitals, medical groups, and other medical facilities. Kanon Ventures has a unique perspective on and understanding
of the healthcare delivery system. More information is available at kanonventures.com.
About Hooper Holmes
Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory
testing, risk assessment and sample collection services to wellness and disease management companies, employers and
brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions
Henry Dubois, President and CEO of Hooper Holmes commented, "This capital will support our growth and liquidity
and help continue to drive our business forward. We also look forward to benefitting from Kanon's experience in the
healthcare market, and their track record in building long-term value."
About Kanon Ventures
Kanon Ventures, LLC is a private equity firm with expertise in healthcare and real estate. For over 30 years, Kanon's
principals and management team have been industry-leading investors and operators, having owned and operated
hospitals, medical groups, and other medical facilities. Kanon Ventures has a unique perspective on and understanding
of the healthcare delivery system. More information is available at kanonventures.com.
About Hooper Holmes
Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory
testing, risk assessment and sample collection services to wellness and disease management companies, employers and
brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions
brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive
health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs.
Hooper Holmes Confidential
2
More information is available at hooperholmes.com and at accountablehealthsolutions.com.
This press release contains “forward-looking” statements, as such term is defined in the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based on the Company’s current expectations and beliefs
and are subject to a number of risks, uncertainties and assumptions. Among the important factors that could cause
actual results to differ materially from those expressed in, or implied by, these forward-looking statements are our
ability to realize the expected benefits from this acquisition and our strategic alliance with Clinical Reference
Laboratory; our ability to successfully implement our business strategy and integrate Accountable Health Solutions’
business with ours; our ability to retain and grow our customer base; our ability to recognize operational efficiencies
and reduce costs; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to
maintain compliance with the financial covenant in our credit facility and the financing for this acquisition; and the
rate of growth in the Health and Wellness market. Additional information about these and other factors that could
affect the Company’s business is set forth in the Company’s annual report on Form 10-K for the year ended December
31, 2014, filed with the Securities and Exchange Commission on March 31, 2015. The Company undertakes no
obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances
after the date of this press release to reflect the occurrence of unanticipated events, except as required by law.
###
Hooper Holmes Confidential
1 Hooper Holmes, Inc. March, 2016 2016-03 Corporate Overview Presented By: Henry Dubois, Chief Executive Officer
2 Safe Harbor Statement 2 This presentation contains forward-looking statements, as such term is defined in the Private Securities Litigation Reform Act of 1995, concerning the Company’s plans, objectives, goals, strategies, future events or performances, which are not statements
of historical fact and can be identified by words such as: “expect,” “continue,” “should,” “may,” “will,” “project,” “anticipate,” “believe,” “plan,” “goal,” and similar references to future periods. The forward-looking statements contained in this presentation reflect our current beliefs
and expectations. Actual results or performance may differ materially from what is expressed in the forward looking statements. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, the forward-looking statements
contained in this presentation are our ability to realize the expected benefits from the acquisition of Accountable Health Solutions and our strategic alliance with Clinical Reference Laboratory; our ability to successfully implement our business strategy and integrate Accountable
Health Solutions’ business with ours; our ability to retain and grow our customer base; our ability to recognize operational efficiencies and reduce costs; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the
financial covenants contained in our credit facilities; the rate of growth in the Health and Wellness market and such other factors as discussed in Part I, Item 1A, Risk Factors, and Part II, Item 7, Management’s Discussion and Analysis of Financial Conditions and Results of
Operations of our Annual Report on Form 10-K for the year ended December 31, 2014. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances, or to reflect the occurrence of unanticipated
events, after the date of this presentation, except as required by law. This presentation contains information from third-party sources, including data from studies conducted by others and market data and industry forecasts obtained from industry publications. Although the Company
believes that such information is reliable, the Company has not independently verified any of this information and the Company does not guarantee the accuracy or completeness of this information. Any references to documents not included in the presentation itself are qualified by
the full text and content of those documents. During our prepared comments or responses to your questions, we may offer incremental metrics to provide greater insight into the dynamics of our business or our quarterly results, such as references to EBITDA and other measures of
financial performance. Please be advised that this additional detail may be one-time in nature and we may or may not provide an update in the future. These and other financial measures may also have been prepared on a non-GAAP basis. For some of these measures, a
reconciliation schedule showing GAAP versus non-GAAP results has been provided in our press release that was issued after the market closed today.
Hooper Holmes Overview 3 Health & Wellness Annual Sales (in millions) Hooper Holmes focuses on providing health risk assessment services to the Health & Wellness Industry 116 Year-old Start-up Positioned to Grow Health & Wellness segment started in 2007 History of
annual Health & Wellness revenue growth Compelling market dynamics and opportunities Major restructuring activities completed Ended 2015 with record Health & Wellness Revenues and significant reduction in net adjusted EBITDA loss Infrastructure created to be
EBITDA positive in 2016 $5 $8 $11 $14 $18 $21 $24 $29 $32 0 5 10 15 20 25 30 35
Turnaround Activities Completed to Build Value 4 2013 – 2014 Sold Non Core Businesses 2014 Adjusted Cost Base 2015 Acquired AHS 2015 H&W Focus 2013 New Management Team 2016 Profitable EBITDA Growth
Expanded Leadership Team Focused on Health & Wellness 5 Henry E. Dubois - President and Chief Executive Officer (April 2013) • As Partner at Tatum, LLC, consulted with Hooper Holmes’ Board and management on strategies to improve growth • Experienced in helping
businesses accelerate performance and create shareowner value • International business leader: C-suite officer with multinational technology and communications companies - several in Asia Pacific • Former consultant with Booz and Company; began career as internal auditor and
finance supervisor for Exxon Steven R. Balthazor - Chief Financial Officer (August 2015) • Senior consultant, providing executive management and hands-on business services to public and private companies • Vice President of Finance for Digital Globe (NYSE: DGI) • Vice
President of Finance and interim CFO for Geo Eye, Inc. . John Bond - Vice President of Provider Relations (July 2012) • Leader in developing health professional networks • Local and national recruiting expert • Developed provider networks for Tufts Health Plan, Blue Cross and
Blue Shield of Vermont and Harvard Pilgrim Health Care Alex B. Thompson - Vice President of Operations (January 2012) • Extensive experience in strategic planning, finance and operational turnarounds • Former Strategic Analyst for Cerner Corporation, a leading healthcare IT
company • Healthcare-based non-profit experience Neil F. Gordon, MD, PhD, MPH, FACC - Medical Director (February 2015) • Author of eight books on preventive medicine and more than 100 scientific articles in peer-reviewed medical journals • Founder, CEO and chief science
officer of INTERVENT International, a provider of evidence-based, lifestyle management and chronic disease risk reduction services Steve Marin - Chief Revenue Officer (October 2015) • 25 years in sales, business development, client service • Former Senior VP of Sales at Chip
Rewards, specialists in incentives to increase healthcare participant engagement • Leadership roles with Alere Health & CorSolution Medical Arielle Band - SVP, Health & Wellness Solutions (April 2015) • Former President of Accountable Health Solutions • Expert in payer,
behavioral health, wellness, disease management and pharmacy benefit manager markets • Previous assignments at Great-West Healthcare, Cigna Healthcare, UnitedHealthcare and Catamaran
2015 Built a Foundation for Growth Acquired Accountable Health Solutions in April 2015 Enables HH to provide broad in-house wellness programs Primary focus on small / mid-sized companies Adds backlog and recurring revenue 2016 will reflect full year of
operations vs ~8 months in 2015 Launched 4 new products in 2015 Wellness Support Now ScreeningPro Enhanced Weight Management with Jenny Craig Rewards Mall Conducted 515,000 screening units in 2015; more than 40,000 unit increase year-over-year $32.1mm
record Health & Wellness revenue in FY2015 6 ~ ~ 2015 New Revenue (in millions) Incremental revenue to be realized in 2016 $7mm
7 Momentum Continues to Build New Sales Won in Q1 2016 and Associated Estimated 2016 Revenue ($mm) 2 0 1 6 n ew sal e s re ve n u e in mill io n $ New Direct Customers Estimated $0.5mm in 2016 Contracts are typically multi-year New Clinical Research Organization
Revenue Estimated $0.9mm in 2016 Large contract extension estimated at $12.0mm in revenue over the life of the contract, $0.8mm in 2016 New Channel Partners Estimated $1.1mm in 2016 New End Customers Through Existing Channel Partners Estimated $0.9mm in
2016 We are positioned to grow with our Channel Partners $0.5 $0.9 $1.1 $0.9 $3.3 $0 $1 $2 $3 $4 2016 Estimated Revenue Impact Total New End Customers Through Channel Partners New Channel Partners New Clinical Research Organizations
Our programs generate changes in behavior for the core health risks driving employer medical trends today 1 2010 World Economic Forum Poor Diet Physical Inactivity Smoking Lack of Health Screening Poor Stress Management Poor Standard of Care Insufficient Sleep Excessive
Alcohol Consumption 8 Risks and Behaviors 1. Diabetes 2. Coronary Artery Disease 3. Hypertension 4. Back Pain 5. Obesity 6. Cancer 7. Asthma 8. Arthritis 9. Allergies 10. Sinusitis 11. Depression 12. Congestive Heart Failure 13. Lung Disease (COPD) 14. Kidney Disease 15.
High Cholesterol Hooper solutions educate and change these poor behaviors that often lead to PREVENTABLE, high-cost conditions driving employer medical trends today Drive 8 15 chronic conditions account for 80% of Total Costs for all chronic illnesses worldwide 1 All other
healthcare costs
Biometric screenings Clinical research support Mobile data collection Portal activities/msg. Team challenges Rewards mall Incentives Email/direct mail Coaching w/medical sensor plans - future Onsite health coaching Telephonic health coaching
Condition management Online content and seminars Health assessment Personal wellness report plans - future 9 Hooper Services Provide End-to-End Integrated Health & Wellness Screening & Data Collection Education Engagement Knowledge Aggregation
10 Why Employers Want Health & Wellness Positive return on every dollar invested Reduced health risks and associated costs Improved employee productivity and morale Attractive employee benefit Investment generates payback
11 Hooper Wellness Programs Get Results Annual healthcare cost reduction of nearly $1.5mm; additional cost savings related to higher productivity, reduced absenteeism, ability to attract and retain top talent, and fewer safety incidents not included $2,680 $5,004 $7,230 $5,952
(Non-Participants) At Start of the Program Risk Transition Two Years Into the Program Low Risk 5,742 (76%) Moderate Risk 1,471 (20%) High Risk 293 (4%) High Risk 183 (3%) Moderate Risk 1,065 (14%) Low Risk 6,258 (83%) Low Risk (n=5,251) Moderate Risk (n=461)
High Risk (n=30) Low Risk (n=899) Moderate Risk (n=491) High Risk (n=81) Low Risk (n=108) Moderate Risk (n=113) High Risk (n=72) Average Annual Healthcare Cost Per Employee 7.3% net change in health risk status improvement 91% of the participants that started as a
low health risk stayed low health risk
12 Market Structure For Current Offerings Full Service Wellness Channel Market Clinical Research Organization Market Size $6.0B (includes screening only market) $2.3B (screening only market) $1.0B Market Growth Est.+8% per annum Est. +8-10% per annum Est. +6-8% per
annum Competitive Landscape High and growing with limited barriers to entry Moderate with large barriers to entry Limited for mobile collections; high for site collections Large opportunity given increasing focus on health Utilization of biometric screenings growing among small
to mid-size companies; higher penetration among larger companies Substantial opportunity in the research market; though mobile data collection value proposition compelling, it is a shift from current methods
Data Collection Services Proprietary Screening Services as a Differentiator 13 Bottom line? Higher quality, faster results, greater engagement into the right programs, at the right time
Our Health Professional Network Coverage for every zip code in the U.S. 14 Hooper Nationwide HP Coverage Right People Right Place Right Equipment Right Information Right Time
Education Services 15
Engagement Services 16 Smart Technology & Multi-Modal Engagement Solutions Smart engagement and analytics engine allows for highly targeted, personalized messaging. Professional quality, multi-modal collateral Flexible Incentive Platform with Meaningful Reward Options
• Flexible plan designs with leading outcomes-based tools and expertise • Sync with leading apps and devices • Rewards Mall to supplement traditional incentives Corporate Team Challenges Boost participation and good results with a side effect of fun, healthy competition,
camaraderie, loyalty, and… you name it! Add BANG and BOOM Participants engage in programs and activities to improve their health Member-specific solutions that are relevant, meaningful and convenient Programs are customizable and can be launched any time of the
year
Knowledge Aggregation – Stratifying an employer’s workforce by areas of risk 17 Class-leading business intelligence informatics pinpoints population health risks, measures engagement rates and helps guide recommendations for continued impact and improvement, and more!
Customer & Client Testimonials 18 “A participant called and wanted to personally thank the examiner she saw the day of her screening. She said her first blood pressure reading was extremely high. The examiner sat with her and tried to calm her down. Since that didn’t appear to be
working, she left work and went to the doctor immediately. Her physician put her on medication and she had to stay overnight in the hospital. They are now working together to monitor and lower her blood pressure. She shared with us that she feels like the examiner sincerely saved
her life.” – Screening participant “The Site Manager and her group did a fantastic job working our event. They were courteous and quick and the professionals everyone wants at their event. Thank you for making our event a true success.” – Channel Partner customer “I want to
express my gratitude for your prompt response and professionalism in carrying out exams for my wife and I. We experienced inclement weather in our area and were not certain about the appointment’s status. You were able to confirm the status and the examiner was at our door
when most people were operating on delayed schedules. She was very thorough, insightful, and articulate in explaining our exam and the impact wellness screening should have on our overall health. The manner of promptness and professionalism is an area that I personally find
lacking in many organizations today. Thanks for your help and professionalism!” – Screening participant “This has been the most well organized, and professionally orchestrated Screening clinic in the history of our onsite program.” – Human Resources Director of a direct customer
19 Q4 2015 Results Set Stage for Accelerated Growth FULL YEAR 2015 HIGHLIGHTS $32.1mm record Health & Wellness revenue 515,000 record screening units Transformed business model, reduced costs New sales in 2015 increased the revenue base for 2016 and
beyond Q4 2014 Q4 2015 +42% REVENUE $6.7mm $9.5mm 2016 OUTLOOK Successfully raised $3.5mm in rights offering and an additional $1.2mm from 200 NNH, LLC an affiliate of Kanon Ventures $42.0mm revenue expected for full year with positive EBITDA &
operating cash flow for full year Q1 is off to a good start Due to the seasonality of the business, ~60% of revenue historically comes in the second half Repayment of $2.3mm of debt planned in 2016 Q4 2014 Q4 2015 +22% GROSS MARGIN % 16.9% 20.7% Q4 2014 Q4
2015 +20% SCREENING UNITS 127,000 152,000
20 Strengthened Capital Structure Rights Offering Successfully Completed in Q1 2016 ̶ Strong interest and shareholder support ̶ Raised $3.5mm ̶ Board and management as a group over subscribed and now hold ~10% of total shares ̶ 300+ individual shareholders participated
Additional Capital Raised in Q1 2016 ̶ 200 NNH, LLC, an affiliate of Kanon Ventures, invested $1.2mm Debt ̶ Repayment of $2.3mm of debt planned for 2016 ̶ Principal payment made in Q1 2016 ̶ Meaningful interest expense reduction with each quarterly payment Cash added
through rights offering $3.5mm Cash added from investment by 200 NNH, LLC $1.2mm $7.0mm Revolving Line of Credit $1.5mm at 3/15 (credit line – amount drawn) SWK Term Loan $4.5mm Current Capital Structure Highlights
21 2015 sales wins expected to drive $7.0mm of incremental revenue in 2016 $3.3mm of new 2016 revenue won through sales efforts already this year, including the addition of full service wellness clients Q1 2016 progressing toward annual goal For full year 2016,
expecting $42.0mm revenue representing 30% growth as compared to 2015 and continued progress toward achieving our $100mm revenue target Expecting positive EBITDA and operating cash flow for the full year New Sales Financial Growth Building Awareness 2016
Outlook: Accelerated Growth Q4 2015: LD Micro Conference February 22nd: Presented at SeeThruEquity Conference March 31st: Sidoti Emerging Growth Conference Drive Shareholder Value